2he4
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==The crystal structure of the second PDZ domain of human NHERF-2 (SLC9A3R2) interacting with a mode 1 PDZ binding motif== | ==The crystal structure of the second PDZ domain of human NHERF-2 (SLC9A3R2) interacting with a mode 1 PDZ binding motif== | ||
- | <StructureSection load='2he4' size='340' side='right' caption='[[2he4]], [[Resolution|resolution]] 1.45Å' scene=''> | + | <StructureSection load='2he4' size='340' side='right'caption='[[2he4]], [[Resolution|resolution]] 1.45Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2he4]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2he4]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HE4 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2HE4 FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.45Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2he4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2he4 OCA], [https://pdbe.org/2he4 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2he4 RCSB], [https://www.ebi.ac.uk/pdbsum/2he4 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2he4 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/NHRF2_HUMAN NHRF2_HUMAN] Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May also act as scaffold protein in the nucleus.<ref>PMID:9096337</ref> <ref>PMID:10455146</ref> |
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 36: | Line 36: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Arrowsmith | + | [[Category: Large Structures]] |
- | [[Category: Berridge | + | [[Category: Arrowsmith C]] |
- | [[Category: Bunkoczi | + | [[Category: Berridge G]] |
- | [[Category: Colebrook | + | [[Category: Bunkoczi G]] |
- | [[Category: Doyle | + | [[Category: Colebrook S]] |
- | [[Category: Edwards | + | [[Category: Doyle DA]] |
- | [[Category: Elkins | + | [[Category: Edwards A]] |
- | [[Category: Gileadi | + | [[Category: Elkins JM]] |
- | [[Category: Gileady | + | [[Category: Gileadi C]] |
- | [[Category: Gorrec | + | [[Category: Gileady O]] |
- | [[Category: Pantic | + | [[Category: Gorrec F]] |
- | [[Category: Papagrigoriou | + | [[Category: Pantic N]] |
- | + | [[Category: Papagrigoriou E]] | |
- | [[Category: Salah | + | [[Category: Salah E]] |
- | [[Category: Savitsky | + | [[Category: Savitsky P]] |
- | [[Category: Sundstrom | + | [[Category: Sundstrom M]] |
- | [[Category: Weigelt | + | [[Category: Weigelt J]] |
- | + | ||
- | + | ||
- | + |
Current revision
The crystal structure of the second PDZ domain of human NHERF-2 (SLC9A3R2) interacting with a mode 1 PDZ binding motif
|
Categories: Homo sapiens | Large Structures | Arrowsmith C | Berridge G | Bunkoczi G | Colebrook S | Doyle DA | Edwards A | Elkins JM | Gileadi C | Gileady O | Gorrec F | Pantic N | Papagrigoriou E | Salah E | Savitsky P | Sundstrom M | Weigelt J